The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection

被引：5
|
作者：
Lai, Peilong [1 ,2 ,3 ]
Chen, Xiaomei [1 ]
Qin, Le [2 ]
Jiang, Zhiwu [2 ]
Luo, Chenwei [1 ]
Huang, Xin [1 ]
Wu, Sujing [1 ]
Ling, Wei [1 ]
Wang, Yulian [1 ]
Wang, Jinghua [1 ]
Deng, Chenxin [1 ]
Huang, Lisi [1 ]
Zeng, Lingji [1 ]
Lu, Zesheng [1 ]
Zhong, Liye [1 ]
Liao, Pengjun [1 ]
Li, Minming [1 ]
Chen, Dongmei [2 ]
Geng, Suxia [1 ]
Wu, Ping [1 ]
Tang, Zhaoyang [4 ]
Pei, Duanqing [2 ,3 ]
Du, Xin [1 ]
Li, Peng [2 ,3 ]
Weng, Jianyu [1 ]
机构：
[1] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Hematol, Guangzhou 510080, Guangdong, Peoples R China
[2] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Univ Chinese Acad Sci, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China
[3] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth,Univ Chinese Acad Sc, Guangzhou 510530, Guangdong, Peoples R China
[4] Guangdong Zhaotai InVivo Biomed Co Ltd, Guangzhou 510000, Peoples R China
来源：
LEUKEMIA | 2020年 / 34卷 / 10期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1038/s41375-020-0952-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2790 / 2793
页数：4
相关论文
共 50 条
  • [1] The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection
    Peilong Lai
    Xiaomei Chen
    Le Qin
    Zhiwu Jiang
    Chenwei Luo
    Xin Huang
    Sujing Wu
    Wei Ling
    Yulian Wang
    Jinghua Wang
    Chenxin Deng
    Lisi Huang
    Lingji Zeng
    Zesheng Lu
    Liye Zhong
    Pengjun Liao
    Minming Li
    Dongmei Chen
    Suxia Geng
    Ping Wu
    Zhaoyang Tang
    Duanqing Pei
    Xin Du
    Peng Li
    Jianyu Weng
    Leukemia, 2020, 34 : 2790 - 2793
  • [2] Efficacy and safety of CAR-T cell therapy in minorities
    Thakkar, Astha
    Abreu, Michelly
    Pradhan, Kith
    Sica, R. Alejandro
    Shastri, Aditi
    Kornblum, Noah
    Shah, Nishi
    Mantzaris, Ioannis
    Gritsman, Kira
    Feldman, Eric
    Elkind, Richard
    Green-Lorenzen, Susan
    Verma, Amit
    Braunschweig, Ira
    Goldfinger, Mendel
    BONE MARROW TRANSPLANTATION, 2022, 57 (07) : 1187 - 1190
  • [3] Efficacy and safety of CAR-T cell therapy in minorities
    Astha Thakkar
    Michelly Abreu
    Kith Pradhan
    R. Alejandro Sica
    Aditi Shastri
    Noah Kornblum
    Nishi Shah
    Ioannis Mantzaris
    Kira Gritsman
    Eric Feldman
    Richard Elkind
    Susan Green-Lorenzen
    Amit Verma
    Ira Braunschweig
    Mendel Goldfinger
    Bone Marrow Transplantation, 2022, 57 : 1187 - 1190
  • [4] Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
    Yurou Chu
    Biqi Zhou
    Rui Gao
    Miao Miao
    Huiying Qiu
    Xiaowen Tang
    Ying Wang
    Suning Chen
    Liqing Kang
    Depei Wu
    Yang Xu
    Blood Cancer Journal, 15 (1)
  • [5] Efficacy and Safety of the Second CAR-T Therapy in Patients with Refractory/Relapsed Acute B-Cell Lymphoblastic Leukemia
    Liu, Sining
    Cui, Qingya
    Li, Zheng
    Cui, Wei
    Li, Mengyun
    Qiu, Huiying
    Xue, Shengli
    Chen, Suning
    Jin, Zhengming
    Miao, Miao
    Han, Yue
    Wang, Ying
    Zhu, Xiaming
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2023, 142
  • [6] Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
    Lakshmi Kattamuri
    Bhavesh Mohan Lal
    Nikhil Vojjala
    Mansi Jain
    Kunal Sharma
    Siddharth Jain
    Samer Al Hadidi
    Rheumatology International, 45 (1)
  • [7] Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma
    Reyes, Kevin R.
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy W.
    Wolf, Jeffrey
    Olin, Rebecca L.
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 350 - 355
  • [8] Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL
    Song, Fengmei
    Hu, Yongxian
    Zhang, Yanlei
    Zhang, Mingming
    Yang, Tingting
    Wu, Wenjun
    Huang, Simao
    Xu, Huijun
    Chang, Alex H.
    Huang, He
    Wei, Guoqing
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (02)
  • [9] Novel technologies for improving the safety and efficacy of CAR-T cell therapy
    Keisuke Ohta
    Yukimi Sakoda
    Koji Tamada
    International Journal of Hematology, 2023, 117 : 647 - 651
  • [10] Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
    de Lima, Marcos
    Di Rocco, Alice
    Ribera, Jose-Maria
    FRONTIERS IN ONCOLOGY, 2024, 14
12345